Literature DB >> 7074405

Effect of nitrous oxide anaesthesia on homocystine excretion.

J C Bevan, D S Rosenblatt, C L Clow, V A Chapman.   

Abstract

Research into the biotransformation of inhaled general anaesthetic agents, including nitrous oxide, has led to a better understanding of the underlying mechanisms. It is now known that nitrous oxide can react chemically with vitamin B12, oxidizing Cob(I)alamin to the inactive Cob(III) alamin form. Clinical and experimental evidence in mammals has confirmed that nitrous oxide toxicity, with symptoms suggestive of clinical vitamin B12 deficiency, occurs on exposure to nitrous oxide in a way which is dose and time related and reversible on withdrawal of the nitrous oxide. Nitrous oxide depresses the two known vitamin B12 dependent enzymes methylmalonyl CoA mutase and methionine synthetase by inactivation of their coenzymes adenosylcobalamin and methylcobalamin respectively. Methionine synthetase catalyses the conversion of homocystine to methionine, so interference with this reaction should cause methionine to be depleted and homocysteine to accumulate and to be excreted in the urine. We postulated that the detection of homocystinuria would therefore be an early indicator of nitrous oxide toxicity. Accordingly, we tested the first urine voided postoperatively of 41 patients undergoing nitrous oxide anaesthesia (17 neonates exposed to 50-66 per cent nitrous oxide for a mean of 3.0 hr, and 24 older patients exposed to 66 per cent nitrous oxide for a mean of 7.2 hr). None of these patients demonstrated homocystinuria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074405     DOI: 10.1007/bf03007127

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  10 in total

1.  Treatment of tetanus; severe bone-marrow depression after prolonged nitrous-oxide anaesthesia.

Authors:  H C LASSEN; E HENRIKSEN; F NEUKIRCH; H S KRISTENSEN
Journal:  Lancet       Date:  1956-04-28       Impact factor: 79.321

2.  Hematologic reaction to prolonged exposure to nitrous oxide.

Authors:  B J Kripke; L Talarico; N K Shah; A D Kelman
Journal:  Anesthesiology       Date:  1977-10       Impact factor: 7.892

3.  Amino acid metabolism and its disorders.

Authors:  C R Scriver; L E Rosenberg
Journal:  Major Probl Clin Pediatr       Date:  1973

4.  Methylmalonic aciduria. An inborn error leading to metabolic acidosis, long-chain ketonuria and intermittent hyperglycinemia.

Authors:  L E Rosenberg; A C Lilljeqvist; Y E Hsia
Journal:  N Engl J Med       Date:  1968-06-13       Impact factor: 91.245

5.  Homocystinuria with methylmalonic aciduria: two cases in a sibship.

Authors:  S I Goodman; P G Moe; K B Hammond; S H Mudd; B W Uhlendorf
Journal:  Biochem Med       Date:  1970-12

6.  A derangement in B 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria.

Authors:  S H Mudd; H L Levy; R H Abeles; J P Jennedy
Journal:  Biochem Biophys Res Commun       Date:  1969-04-10       Impact factor: 3.575

7.  Exposure to nitrous oxide and neurologic disease among dental professionals.

Authors:  J B Brodsky; E N Cohen; B W Brown; M L Wu; C E Whitcher
Journal:  Anesth Analg       Date:  1981-05       Impact factor: 5.108

8.  Selective inactivation of vitamin B12 in rats by nitrous oxide.

Authors:  R Deacon; M Lumb; J Perry; I Chanarin; B Minty; M J Halsey; J F Nunn
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

9.  Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats.

Authors:  H Kondo; M L Osborne; J F Kolhouse; M J Binder; E R Podell; C S Utley; R S Abrams; R H Allen
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Megaloblastic haemopoiesis in patients receiving nitrous oxide.

Authors:  J A Amess; J F Burman; G M Rees; D G Nancekievill; D L Mollin
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.